trending Market Intelligence /marketintelligence/en/news-insights/trending/VqB_Vuh7Xl6XDN7bkaCPRw2 content esgSubNav
In This List

Iovance Biotherapeutics names CFO

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022

Blog

Essential IR Insights Newsletter - February 2023


Iovance Biotherapeutics names CFO

Iovance Biotherapeutics Inc. appointed Timothy Morris to be CFO, effective Aug. 14.

Morris most recently served as CFO and head of business development of AcelRx Pharmaceuticals Inc.